Talk:Cantuzumab ravtansine

This article is rated Stub-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects:

Pharmacology This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology articles ??? This article has not yet received a rating on the project's importance scale.

Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Cantuzumab ravtansine. PubMed provides review articles from the past five years (limit to free review articles) The TRIP database provides clinical publications about evidence-based medicine. Other potential sources include: Centre for Reviews and Dissemination and CDC

Is there an ADC infobox we can use instead ? - Rod57 (talk) 10:04, 26 August 2015 (UTC)[reply]